{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:37:11Z","timestamp":1780627031570,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.yebeh.2015.06.025","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T12:34:55Z","timestamp":1440419695000},"page":"221-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine"],"prefix":"10.1016","volume":"51","author":[{"given":"Hepsen Mine","family":"Serin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra P\u0131nar","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berfin","family":"Temelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130hsan","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2015.06.025_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0221-8747(82)90008-X","article-title":"Bone status of children receiving anticonvulsant therapy","volume":"4","author":"Barden","year":"1982","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00441738","article-title":"Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication","volume":"144","author":"Nishiyama","year":"1986","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2008-1052532","article-title":"Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children","volume":"17","author":"Ala-Houhala","year":"1986","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-1331.2010.03137.x","article-title":"Genetic variation may clarify the relationship between epilepsy, antiepileptic drugs, and bone health","volume":"18","author":"Pack","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2012.09.002","article-title":"Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy","volume":"104","author":"Koo","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.seizure.2007.11.024","article-title":"How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies","volume":"17","author":"Nissen-Meyer","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2013.08.012","article-title":"The effect of levetiracetam on rat bone mass, structure and metabolism","volume":"107","author":"Fekete","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/epi.12162","article-title":"Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy","volume":"54","author":"Phabphal","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1759720X11410769","article-title":"Antiepileptics and bone health","volume":"3","author":"Meier","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0050","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.wnl.0000310981.44676.de","article-title":"Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy","volume":"70","author":"Pack","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02556465","article-title":"Increased circulating levels of \u0263-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy","volume":"44","author":"Takeshita","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0887-8994(98)00039-3","article-title":"Evaluation of bone mineral density in children receiving antiepileptic drugs","volume":"19","author":"Akin","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1515\/JPEM.2000.13.7.933","article-title":"Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid","volume":"13","author":"Erbayat Altay","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0070","first-page":"221","article-title":"Antiepileptik ila\u00e7lar\u0131n kemik metabolizmas\u0131na etkilerinin de\u011ferlendirilmesi","volume":"40","author":"Giray","year":"2005","journal-title":"T\u00fcrk Pediatri Ar\u015fivi"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1442-200X.2002.01561.x","article-title":"Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy","volume":"44","author":"Tsukahara","year":"2002","journal-title":"Pediatr Int"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0080","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/00207450290158269","article-title":"No effect of long-term valproate therapy on thyroid and parathyroid functions in children","volume":"112","author":"Caksen","year":"2002","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000992289903800205","article-title":"Effect of antiepileptic drugs on bone in children between ages 6 and 12years","volume":"38","author":"Kafal\u0131","year":"1999","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0090","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1442-200X.2002.01561.x","article-title":"Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy","volume":"44","author":"Tsukahara","year":"2002","journal-title":"Pediatr Int"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/14740338.2011.534455","article-title":"Influences of bone and mineral metabolism in epilepsy","volume":"10","author":"Hamed","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.seizure.2007.11.018","article-title":"Long term levetiracetam treatment affects reproductive endocrine function in female Wistar rats","volume":"17","author":"Svalheim","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0105","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure and metabolism","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP12119.OR","article-title":"The association of newer anticonvulsant medications and bone mineral density","volume":"14","author":"Lee","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.yebeh.2015.06.025_bb0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.seizure.2012.04.002","article-title":"Bone mineral density in adult patients treated with various antiepileptic drugs","volume":"21","author":"Beniczky","year":"2012","journal-title":"Seizure"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501500356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501500356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T19:22:26Z","timestamp":1567106546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501500356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":23,"alternative-id":["S152550501500356X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.06.025","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}